Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000250520 | SCV000306073 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000250520 | SCV001360977 | benign | not specified | 2019-08-12 | criteria provided, single submitter | clinical testing | Variant summary: RYR2 c.7342+16A>G alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0048 in 249216 control chromosomes, predominantly at a frequency of 0.023 within the East Asian and African-American subpopulations in the gnomAD database, including 9 homozygotes. The observed variant frequency within East Asian and African-American control individuals in the gnomAD database is approximately 383-folds over the estimated maximal expected allele frequency for a pathogenic variant in RYR2 causing Arrhythmia phenotype (6e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian and African-American origins. To our knowledge, no occurrence of c.7342+16A>G in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. |
ARUP Laboratories, |
RCV001610603 | SCV001473988 | benign | not provided | 2020-03-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610603 | SCV001840613 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002518600 | SCV002408187 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000250520 | SCV001918760 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000250520 | SCV001972103 | benign | not specified | no assertion criteria provided | clinical testing |